Richard L. M. Faull

Active 1968–2025

212
Papers
33,353
Citations
105
h-index
203
i10-index

Citations

Citations per year for Richard L. M. Faull1932: 2 citations1969: 5 citations1970: 1 citations1971: 11 citations1972: 9 citations1973: 7 citations1974: 4 citations1975: 1 citations1976: 6 citations1977: 6 citations1978: 10 citations1979: 34 citations1980: 50 citations1981: 30 citations1982: 31 citations1983: 35 citations1984: 32 citations1985: 39 citations1986: 26 citations1987: 26 citations1988: 32 citations1989: 23 citations1990: 70 citations1991: 89 citations1992: 117 citations1993: 103 citations1994: 124 citations1995: 103 citations1996: 134 citations1997: 127 citations1998: 115 citations1999: 133 citations2000: 175 citations2001: 144 citations2002: 138 citations2003: 188 citations2004: 204 citations2005: 207 citations2006: 215 citations2007: 284 citations2008: 278 citations2009: 277 citations2010: 291 citations2011: 293 citations2012: 223 citations2013: 239 citations2014: 308 citations2015: 252 citations2016: 231 citations2017: 244 citations2018: 291 citations2019: 833 citations2020: 1,138 citations2021: 1,140 citations2022: 987 citations2023: 717 citations2024: 1,203 citations2025: 621 citations2026: 15 citations1933–1968: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,630 citing papers, 30% of this breakdownUnited Kingdom: 1,235 citing papers, 8% of this breakdownChina: 1,142 citing papers, 7.4% of this breakdownGermany: 777 citing papers, 5% of this breakdownCanada: 668 citing papers, 4.3% of this breakdownItaly: 638 citing papers, 4.1% of this breakdownFrance: 517 citing papers, 3.4% of this breakdownAustralia: 474 citing papers, 3.1% of this breakdownSpain: 468 citing papers, 3% of this breakdownJapan: 422 citing papers, 2.7% of this breakdownNew Zealand: 356 citing papers, 2.3% of this breakdownNetherlands: 341 citing papers, 2.2% of this breakdown
0%30%Other 24.5%

Fields

  • Neuroscience40.5%
  • Medicine31.7%
  • Biochemistry, Genetics and Molecular Biology18.9%
  • Dentistry3.7%
  • Immunology and Microbiology1.2%
  • Nursing0.8%
  • Other3.2%

Topics

  • Neuroscience and Neuropharmacology Research6.6%
  • Alzheimer's disease research and treatments5%
  • Genetic Neurodegenerative Diseases4.1%
  • Neuroinflammation and Neurodegeneration Mechanisms3.6%
  • Mitochondrial Function and Pathology2.9%
  • Neurogenesis and neuroplasticity mechanisms2.7%
  • Other75.1%

Coauthors

All papers

Open in search
  1. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2019 cited by 1,848

  2. Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?

    Authors: , , , , , , - Journal of Clinical Medicine 2019 cited by 287

  3. Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease

    Authors: , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 158

  4. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 545

  5. The Role of Microglia and Astrocytes in Huntington’s Disease

    Authors: , , , - Frontiers in Molecular Neuroscience 2019 cited by 242

  6. Neutrophil-vascular interactions drive myeloperoxidase accumulation in the brain in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , - Acta Neuropathologica Communications 2022 cited by 123

  7. Characterisation of PDGF-BB:PDGFRβ signalling pathways in human brain pericytes: evidence of disruption in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Communications Biology 2022 cited by 107

  8. The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients

    Authors: , , , , , , , - Scientific Reports 2017 cited by 250

  9. Applying the Bradford Hill Criteria for Causation to Repetitive Head Impacts and Chronic Traumatic Encephalopathy

    Authors: , , , , , , , , , , , , , - Frontiers in Neurology 2022 cited by 174

  10. Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus

    Authors: , , , , - International Journal of Molecular Sciences 2020 cited by 83

  11. Aggregate-prone brain regions in Parkinson’s disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibility

    Authors: , , , , , , - npj Parkinson s Disease 2024 cited by 73

  12. TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function

    Authors: , , , , , , , , , , - Journal of Neuroinflammation 2016 cited by 200

  13. Current and Possible Future Therapeutic Options for Huntington’s Disease

    Authors: , , , , , - Journal of Central Nervous System Disease 2022 cited by 117

  14. Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men

    Authors: , , , , , , , - Glia 2012 cited by 216

  15. Regional and cellular gene expression changes in human Huntington's disease brain

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2006 cited by 834

  16. Markers for human brain pericytes and smooth muscle cells

    Authors: , , , , , , - Journal of Chemical Neuroanatomy 2018 cited by 269

  17. The GABAergic system as a therapeutic target for Alzheimer's disease

    Authors: , , , , , - Journal of Neurochemistry 2018 cited by 184

  18. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain

    Authors: , , , , , - Neurobiology of Aging 2013 cited by 348

  19. PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia

    Authors: , , , , , , , , , , , , , , , , - Molecular Neurodegeneration 2018 cited by 171

  20. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

    Authors: , , - Neuroscience 1997 cited by 1,047

  21. Unique and shared inflammatory profiles of human brain endothelia and pericytes

    Authors: , , , , , , , , , , - Journal of Neuroinflammation 2018 cited by 138

  22. Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer’s disease

    Authors: , , , , , , , - Biochemical and Biophysical Research Communications 2020 cited by 112

  23. Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia

    Authors: , , , , , , , , - Metallomics 2017 cited by 111

  24. The Neuropathology of Huntington’s Disease

    Authors: , , , , - Current topics in behavioral neurosciences 2014 cited by 327